Savara Inc.
NASDAQ:SVRABiotechnology
Healthcare
$4.72 +0.46%
+$0.03 today
- Market cap
- $1.04B
- Beta
- 0.27
- P/E (TTM)
- -10.6
- EPS (TTM)
- -$0.51
52W Low $1.98High $7.01
Volume 5.51M
Average 1.53M
Price history
Savara Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+2.61%
Period high
$6.94
Period low
$4.22
Latest
$4.72
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| S-8 | Aug 11, 2026 | Aug 11, 2026 | |
| 4 | Jul 24, 2026 | Jul 24, 2026 | |
| 4 | Jun 22, 2026 | Jun 22, 2026 | |
| 8-K | Jun 8, 2026 | Jun 8, 2026 | |
| 10-Q | May 12, 2026 | May 12, 2026 | |
| ARS | Apr 24, 2026 | Apr 24, 2026 | |
| DEF 14A | Apr 24, 2026 | Apr 24, 2026 | |
| DEFA14A | Apr 24, 2026 | Apr 24, 2026 | |
| PRE 14A | Apr 10, 2026 | Apr 10, 2026 | |
| 4 | Mar 20, 2026 | Mar 20, 2026 | |
| 10-K | Mar 13, 2026 | Mar 13, 2026 | |
| 8-K | Mar 13, 2026 | Mar 13, 2026 |
Competitors
Who does Savara Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about SVRA's filings, answered from its disclosures.
What is the latest SVRA filing?
The latest filing shown is 10-Q dated Nov 9, 2026.
How many recent filings does SVRA have?
Intrinsic Alpha currently shows 20 recent filings for SVRA.
Continue the stock analysis
Jump to another research area for this company.